- Home
- APPF vs RVMD Comparison
APPF vs RVMD Comparison
Compare APPF & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APPF | RVMD |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 7.5B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | APPF | RVMD |
|---|---|---|
| Price | $224.99 | $79.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 18 |
| Target Price | ★ $310.75 | $77.11 |
| AVG Volume (30 Days) | 208.1K | ★ 2.2M |
| Earning Date | 01-29-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.16 | N/A |
| EPS | ★ 5.58 | N/A |
| Revenue | ★ $906,294,000.00 | N/A |
| Revenue This Year | $21.87 | N/A |
| Revenue Next Year | $18.51 | $714.50 |
| P/E Ratio | $41.44 | ★ N/A |
| Revenue Growth | ★ 18.88 | N/A |
| 52 Week Low | $190.24 | $29.17 |
| 52 Week High | $326.04 | $81.49 |
Technical Indicators
Market Signals| Indicator | APPF | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 74.32 |
| Support Level | $229.25 | $77.54 |
| Resistance Level | $239.00 | $80.44 |
| Average True Range (ATR) | 5.77 | 2.44 |
| MACD | 0.25 | -0.52 |
| Stochastic Oscillator | 13.79 | 72.95 |
Price Performance
Historical ComparisonAbout APPF AppFolio Inc.
AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.